Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

El.En.

Investor Presentation • Mar 21, 2022

4393_cp_2022-03-21_19a1386f-dd10-4b08-a8b8-fc2a2b227e20.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

COMPANY PRESENTATION

EURONEXT STAR CONFERENCE

March 22, 2022

DISCLAIMER

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-lookingstatements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.

AGENDA

  • 1.Overview
  • 2.Markets and Growth drivers
  • 3.Innovation: products & applications
  • 4.Financial Highlights
  • 5.Current Outlook
  • 6.Multiples & Comparables

A primary player providing Medical, Industrial and Conservation Laser Solutions Worldwide

World Class Hi-Tech company

Hi-Tech industrial group providing laser solutions with proprietary technologies and know how developed over 40 years

Listed on Milan's Stock Exchange Star segment since year 2000

Within Worldwide leaders in its space

Active worldwide on several laser application segments and markets…

…progressively widening its worldwide presence achieving continuous growth over the years

WE CREATE LIGHT, ENERGY, WAVES

Medical

Our energy based systems improve people's well-being and life quality.

In the surgical sector, our minimally invasive technology systems minimize pain, side effects and risks of surgical procedures andhospitalization days.

In the aesthetic sector, our systems satisfy the growing desire of individuals to improve their appearance also reducing pathological or painful imperfections

Conservation

Our laser systems preserve artworks of the universal heritage of our communities.

Industrial

Our laser cutting and marking systems reduce the environmental impact of manufacturing processes minimizing waste, fumes generated by the process, use of chemical additives, also allowing to eliminate the need for inks, solvents or glues within the process.

6

Coolwaves® by (Deka Mela S.r.l.) first body-contouring microwaves

Incorporation of EsthelogueS.r.l.

MediostarNext(Asclepion GmbH)

Cutlite Penta S.r.l. costituisce la seconda joint venture cinese Penta Laser Equipment (Wenzhou) Co.Ltd

Juliet® (Asclepion GmbH) for vagina atrophy

organizations under the Reinassance® brand

con Moveo (Deka Mela S.r.l.) hair removal and

Deka M.E.L.A.S.r.l.and Quanta System S.p.A. join the Italian sales

2011

2013

2016

MotusAX

2018

ONDA

system

pigmented lesions

2010

SmartXide2 (Deka Mela S.r.l.) CO2 laser with RF laser source for dermatologicand aesthetic surgery

(Cutlite Penta S.r.l.) Laser Cutting system with

PlusRF

for hair removal 2012

2009

El.En.RF laser sourceo

MonnaLisaTouch® (Deka Mela S.r.l.) for vaginal atrophy treatment

Cyber(Quanta System S.p.A.) surgical device for stones and BPH

2015

Bolt(Penta Chutian e Wenzhou - Cina) high power laser metal cutting system

Discovery Pico (Quanta System S.p.A.) tatoo removal, pigmented lesions and dermatologic treatments

HIROTT (ASA S.r.l.) painful pathologies of the musculoskeletal system

Fiber Plus(Cutlite Penta S.r.l.) first fiber laser metal cutting system

2017

RF 1222"The Big Boy"

2019

Incorporation in Lin Yi of Penta LaserTechnology (Shangdong) Co.Ltd

Glide (dermatology)

2020

Schwarzy (magnetotherapy) Red Touch (derm) Again (hair removal) and Dr. 2021Arnold (magnetotherapy)

Markets and Growth drivers

Laser surgery market trends

Minimally invasive surgeries:

Painless procedures

  • Lower risks and side effects
  • Shorter hospital stays/Faster recovery
  • Savings by Private & National Health Systems

  • Attractive ROI for surgical services providers

  • Rapidly Growing Urology laser market

  • Mordor intelligence: 5,51% 2019-2027 CAGR from \$1Bn in 2020

Medical Aesthetics market trend

  • Aging demographics and increasing focus on improving appearance and youthfulness;
  • Growing interest in non-invasive or minimallyinvasive procedures and awareness of energybased aesthetic treatments
  • Growing global obesity rate
  • Reductions in procedure costs, attracting a broader patient base
  • Normalization and social acceptance of cosmetic procedures
  • Rapid growth expected
  • Decision Market Reports: CAGR 16,5% to 2027
  • Daniel Associates CAGR 10,23 to 2023
  • Fortune Business Insights CAGR 13,9 to 2027
  • Mordor Intelligence CAGR 11,08% to 2026

Medical Aesthetics: our multi-brand approach

Industrial lasers market trend

Laser cutting applications:

  • Laser power increase + Cost reduction: enhanced flexibility, productivity and quality standards in manufacturing processes
  • New application verticals

  • Building and construction

  • Products identification and traceability

  • Minimal environmental impact

HAIR REMOVAL DEVICES

BODY CONTOURING DEVICES

Skin Devices

Discovery Pico Smart Pico

Unique high end system for laser hair removal

Luxea

The ultimate multi application and multi technology platform

RED Touch

The system for neocollagenesis and tissue regeneration

Urology

FIBER DUST

One of two worldwide players in high power medical fiber lasers

Our novel disruptive technology for the most effective stones micro fragmentation

MonnaLisaGlide- Duoglide

Novel CO2 device for dermatology and gynecology featuring an additional 1540nm laser source

Physiotherapy

MiS (MLS Family) For degenerative neuropathies

Industrial lasers systems

STEEL CUTTING

10 kW Average power in 2020 sales bookings40 kW systemsto come in 2021

Laser cutting systems offer in China

Financial Highlights

Income Statement – FY 2021

'0
E
0
0
u
r
o		 /
/
3
1
1
2
1
9		 % /
/
3
1
1
2
2
0		 % /
/
3
1
1
2
2
1		 % C
%
a
g
r
d
d
i
t
u
n
a
u
e
d
l
M
i
e
c
a		 2
4
2.
1
8
4		 6
0,
4
%		 2
2
9.
0
6
1		 5
6,
1
%		 3
1
1.
2
9
0		 5
4,
5
%		 1
3,
4
%
d
l
I
i
t
n
u
s
r
a		 1
5
8.
5
7
7		 3
9,
6
%		 1
7
9.
0
2
3		 4
3,
9
%		 2
6
0.
1
1
2		 4
5,
5
%		 2
8,
1
%
R
e
v
e
n
u
e
s		 4
0
0.
7
6
1		 %
1
0
0,
0		 4
0
8.
0
8
3		 %
1
0
0,
0		 5
7
1.
4
0
2		 %
1
0
0,
0		 %
1
9,
4
G
i
r
o
s
s
m
a
r
g
n		 6.
0
2
1
5
1		 3
8,
9
%		 6
3
1
4
1.
7		 3
%
4,
7		 2
2.
0
3
1
7		 3
%
7,
1		 6,
6
%
1
O
i
E
t
p
e
r
a
n
g
p
e
n
s
e
s
x		 4
3.
6
2
4		 1
0,
9
%		 3
4.
1
3
1		 8,
4
%		 4
7.
8
1
2		 8,
4
%		 4,
7
%
f
f
S
t
a
e
s
p
e
n
s
e
s		 6
6.
0
8
5		 1
6,
5
%		 6
6.
6
9
2		 1
6,
3
%		 8
4.
1
7
0		 1
4,
7
%		 1
2,
9
%
E
B
I
T
D
A		 4
6.
3
1
2		 1
1,
6
%		 4
0.
8
1
4		 1
0,
0
%		 8
0.
0
9
1		 1
4,
0
%		 3
1,
5
%
l
D
t.
e
p
r.,
a
m
o
r
a
c
c
r
u
a
s
,		 8.
1
1
4		 %
2,
0		 1
0.
7
0
3		 %
2,
6		 1
5.
2
3
4		 %
2,
7		 %
3
7,
0
I
E
B
T		 3
8.
1
9
8		 9,
%
5		 3
0.
1
1
1		 4
%
7,		 6
4.
8
8
5		 1
1,
4
%		 3
0,
3
%
f
(
h
)
i
i
N
t
e
n
a
n
c.
n
c
o
m
e
c
a
r
g
e
s		 4
6
8		 0,
1
%		 (
)
1.
6
2
7		 0,
4
%
-		 1.
2
7
5		 0,
3
%		 9
3,
4
%
(
)
h
O
i
t
t
e
r
n
c
o
m
e
e
p
e
n
s
e
n
e
x		 (
)
2
3		 0,
0
%		 (
)
4
2
5		 0,
1
%
-		 (
)
1
8
5		 0,
0
%		 1
8
5,
3
%
E
B
T		 3
8.
6
4
4		 %
9,
6		 2
7.
9
2
4		 %
6,
8		 6
6.
4
2
4		 %
1
1,
6		 %
3
1,
1
I
t
n
c
o
m
e
a
x
e
s		 9.
8
6
8		 2,
%
5		 3
8
2
5.		 3
%
1,		 3
0
0
1
7.		 3,
0
%		 3
2,
%
4
i
i
i
M
t
n
o
r
e
s		 2.
9
7
5		 0,
%
7		 2.
2
8
7		 0,
6
%		 3.
6
8
8		 0,
6
%		 6
%
1
5,
N
I
N
C
O
E
T
M
E		 2
6.
0
1
7		 6,
%
5		 2
0.
2
5
5		 0
%
5,		 4
4
3
6
5.		 8,
0
%		 3
2,
2
%

Balance sheet – 2021

'0
E
0
0
u
r
o		 /
/
3
1
1
2
2
0		 /
/
3
1
1
2
2
1		 %
V
a
r.
d
d
i
t
u
n
a
u
e
l
T
t
t
t
o
a
n
o
n
c
u
r
r
e
n
a
s
s
e
s		 6
8
3
8
1
1		 3
6
6
8
1
4		 0
%
1
7
,
k
l
i
C
i
N
W
t
t
e
o
r
n
g
a
p
a		 0
6
9
1
1
7		 6
1
4
4
4
1		 3
0
%
7
,
/
h
b
l
b
l
O
i
S
T
t
e
r
r
e
c
e
a
e
s
p
a
a
e
s
v
y		 (
)
3
7
9
4
6		 (
)
9
1
2
7
8		 1
4
0
5
%
,
f
l
N
i
i
i
i
t
t
e
n
a
n
c
a
p
o
s
o
n		 6
4
1
6
8		 1
1
5
7
6
6		 8
0
4
%
,
l
b
l
L
i
i
i
i
t
t
o
n
g
e
r
m
a
e
s		 1
3
0
7
4		 1
8
0
7
6		 %
3
8
3
,
N
E
i
t
t
e
q
u
y		 2
4
0
6
6
5		 2
8
7
7
0
1		 %
1
9
5
,
l
l
d
i
N
t
t
e
c
a
p
a
e
m
p
o
y
e		 1
7
6
4
9
7		 1
7
1
9
3
5		 %
2,
6
-
k
l
l
i
C
i
N
W
t
t
e
o
r
n
g
a
p
a
o
n
s
a
e
s		 2
%
7,
1		 2
3
%
5
,
O
C
R
E		 %
1
7,
1		 3
%
7
7
,
/
(
)
l
l
d
i
E
B
I
T
N
t
t
e
c
a
p
a
e
m
p
o
y
e
C
a
p
e
x		 1
2
9
4
1		 2
3
1
5
0

Revenue breakdown by area

2022 vs 2021:

Revenue increase > +10%

EBIT 2022 > EBIT 2021

Multiples & ComparablesCurrent Outlook

Multiples

k
h
l
d
's
i
h
S
E
t
t
o
c
o
e
r
q
p
e
r
s
a
r
e
u
y		 3,
6
/
k
l
d
i
j.
P
B
V
A
r
c
e
o
o
a
u
e		 3,
8
/
(
)
9
0
%
E
V
E
B
I
T
E
B
I
T		 6,
3
1
/
(
)
l
l
E
V
S
9
0
%
S
a
e
s
a
e
s		 1,
8
l.
k
E
E
M
C
t
n
a
r
e
a
p		 1.
0
8
3,
8
@		 €
1
3,
5
8
f
l
i
i
i
i
N
t
t
e
n
a
n
c
a
p
o
s
o
n		 @
1
1
5,
8		 /
/
3
1
1
2
2
1
/
i
i
l
i
l
F
t
t
t
n
a
n
c
a
n
e
s
m
e
n
s
m
e
r
m
v		 @
1
8,
4		 /
/
3
1
1
2
2
1
l
i
E
V
t
n
e
r
p
r
s
e
a
u
e		 9
9,
4
7

Comparables

De
3
1st
2
0
2
1
c.
,
/
d
l
he
Me
ica
Ae
ic
st
t		 Pr
ice		 Re
ve
nu
e		 Va
%
r.
Re
v.		 EB
I
T		 EB
I
T
%		 M
K.
Ca
p.		 E
V		 /
les
E
V
Sa		 /
E
V
EB
I
T		 /
P
E		 /
k
P
Bo
o
lue
Va
Cu
te
ra		 \$
4
4,
8
7		 \$
2
3
1		 5
7
%		 \$
2		 1
%		 \$
8
0
8		 \$
7
9
3		 3,
4		 4
3
3,
4		 3
8
4,
7		 1
4,
3
de
In
Mo		 \$
3
8,
0
1		 \$
3
0
4		 %
7
3		 \$
1
6
7		 %
5
5		 \$
3.
1
1
0		 \$
2.
6
9
8		 8,
9		 1
6,
1		 1
6,
3		 7,
5
(
)
Ve
2
nu
s		 \$
1,
3
9		 \$
7
3		 4
0
%		 \$
(
)
1
1		 -15
%		 \$
7
6		 \$
1
3
7		 1,
4		 n.a n.a 2,
7
d
l
S
isr
M
ica
am
e		 \$
1,
1
3		 \$
2
9
4		 8
2
%		 \$
4
3		 1
4
%		 \$
5
25		 \$
4
3
0		 1,
5		 1
0,
1		 1
3,
2		 1,
5
ic
Lu
tro
n		 €
1
8,
7
3		 €
1
2
8		 %
5
2		 €
2
2		 %
17		 €
4
6
9		 €
4
3
4		 3,
4		 1
9,
7		 2
1,
2		 5,
5
du
ia
l
In
str
G
ho
ics
Co
I
P
P
to
n		 \$
6,
0
6
1
1		 \$
6
1.
4
1		 2
2
%		 \$
3
6
8		 25
%		 \$
6.
0
1
4		 \$
6
6
4.
1		 3,
2		 2,
1
7		 6,
1
7		 2,
2
im
du
ie
Pr
In
str
a		 €
15
7
6
,		 €
4
0
8		 2
2
%		 €
1
4		 3
%		 €
1
6
5		 €
2
3
4		 0,
6		 1
6,
6		 2
9,
1		 1,
0
's
Ha
La
n
se
r		 ¥
4
1,
5
4		 ¥
1
6.
3
17		 %
3
6		 ¥
2.
25
4		 %
1
4		 ¥
4
3.
0
5
0		 ¥
4
5.
0
0
2		 2,
8		 2
0,
0		 2
2,
5		 3,
7
ic
By
str
on		 C
H
9
9
F
7		 C
H
9
3
9
F		 17
%		 C
H
0
F
7		 %
7		 C
H
1.
8
0
F
5		 C
H
1.
3
6
0
F		 1,
4		 1
9,
4		 2
3,
9		 2,
3
l.
(
)
E
En
1		 €
1
3,
5
8		 €
5
7
1		 %
4
0		 €
6
5		 %
1
1		 €
1.
0
8
4		 €
9
5
0		 1,
8		 1
6,
3		 2
0,
9		 3,
8

Amounts in mln

(1) EV and multiplies as for previous slide

(2) Financials on Sept. 30th, 2021

Contacts

El.En. S.P.A.

Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: [email protected]

POLYTEMS HIR

Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI - [email protected] Silvia MARONGIU - [email protected] Tel. +39 06-69923324

More from El.En.

Regulatory Filings 2025
Dec 22
Transaction in Own Shares 2025
Dec 22
Share Issue/Capital Change 2025
Dec 22
Transaction in Own Shares 2025
Dec 3
Investor Presentation 2025
Dec 3
Report Publication Announcement 2025
Dec 3
Report Publication Announcement 2025
Dec 3
Registration Form 2025
Nov 28
Share Issue/Capital Change 2025
Nov 28
Share Issue/Capital Change 2025
Nov 28
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.